XML 36 R25.htm IDEA: XBRL DOCUMENT v3.26.1
Cash and Marketable Securities (Tables)
3 Months Ended
Mar. 31, 2026
Cash and Cash Equivalents [Abstract]  
Summary of Cash and Cash Equivalents
A reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets to the amount reported within the condensed consolidated statements of cash flows is shown in the table below (in thousands):
March 31, 2026March 31, 2025
Cash and cash equivalents$77,923 $88,745 
Restricted cash551 550 
Total cash, cash equivalents and restricted cash at the end of the period
$78,474 $89,295 
Summary of Restricted Cash
A reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets to the amount reported within the condensed consolidated statements of cash flows is shown in the table below (in thousands):
March 31, 2026March 31, 2025
Cash and cash equivalents$77,923 $88,745 
Restricted cash551 550 
Total cash, cash equivalents and restricted cash at the end of the period
$78,474 $89,295 
Summary of Marketable Securities
The amortized cost, unrealized holding gains and losses and fair value of the Company’s marketable securities by major security type at each balance sheet date are summarized in the tables below (in thousands):
March 31, 2026
Amortized Cost
Unrealized Holding Losses
Fair Value
Marketable securities:
U.S. agency securities
$73,696 $(48)$73,648 
Corporate debt securities46,458 (99)46,359 
Total marketable securities
$120,154 $(147)$120,007 
December 31, 2025
Amortized Cost
Unrealized Holding Gains
Fair Value
Marketable securities:
U.S. agency securities$81,196 $595 $81,791 
Corporate debt securities54,748 57 54,805 
Total marketable securities
$135,944 $652 $136,596